中国综合临床
中國綜閤臨床
중국종합림상
Clinical Medicine of China
2015年
9期
831-834
,共4页
王子锋%张宏%杨群%黄忠%张鑫琦%牛心慧%相延庆
王子鋒%張宏%楊群%黃忠%張鑫琦%牛心慧%相延慶
왕자봉%장굉%양군%황충%장흠기%우심혜%상연경
良性前列腺增生%钬激光前列腺剜除术%经尿道等离子前列腺剜除电切术
良性前列腺增生%鈥激光前列腺剜除術%經尿道等離子前列腺剜除電切術
량성전렬선증생%화격광전렬선완제술%경뇨도등리자전렬선완제전절술
Benign prostatic hyperplasia%Holmium laser enucleation of the prostate%Plasmakineticenucleation of the prostate
目的 评价并对比钬激光前列腺剜除术(HoLEP)和经尿道等离子前列腺剜除电切术(PKEP)治疗良性前列腺增生(BPH)的临床效果.方法 选择我院2013年1月至2014年6月BPH患者共86例,分别接受HoLEP(HoLEP组,40例)或PKEP(PKEP组,46例)治疗,评价两组患者手术前及术后3个月残余尿量(PVR)、国际前列腺症状评分(IPSS),生活质量(QOL)评分,最大尿流率(MFR)等指标,并记录术中出血量、手术时间、切除前列腺质量、膀胱冲洗时间、留置导尿时间、术后住院时间等围手术期相关指标.结果 术后3个月,两组PVR、IPSS、QOL、MFR等指标较术前均显著改善(P值均为0.000),但组间比较差异均无统计学意义(P均＞0.05);HoLEP组术中出血量低于PKEP组[(69.5±23.6) ml与(87.5±38.0)ml,P=0.011],其余指标比较差异均无统计学意义(P均＞0.05).结论 HoLEP和PKEP治疗前列腺良性增生的临床效果相当,但HoLEP出血量更少.
目的 評價併對比鈥激光前列腺剜除術(HoLEP)和經尿道等離子前列腺剜除電切術(PKEP)治療良性前列腺增生(BPH)的臨床效果.方法 選擇我院2013年1月至2014年6月BPH患者共86例,分彆接受HoLEP(HoLEP組,40例)或PKEP(PKEP組,46例)治療,評價兩組患者手術前及術後3箇月殘餘尿量(PVR)、國際前列腺癥狀評分(IPSS),生活質量(QOL)評分,最大尿流率(MFR)等指標,併記錄術中齣血量、手術時間、切除前列腺質量、膀胱遲洗時間、留置導尿時間、術後住院時間等圍手術期相關指標.結果 術後3箇月,兩組PVR、IPSS、QOL、MFR等指標較術前均顯著改善(P值均為0.000),但組間比較差異均無統計學意義(P均＞0.05);HoLEP組術中齣血量低于PKEP組[(69.5±23.6) ml與(87.5±38.0)ml,P=0.011],其餘指標比較差異均無統計學意義(P均＞0.05).結論 HoLEP和PKEP治療前列腺良性增生的臨床效果相噹,但HoLEP齣血量更少.
목적 평개병대비화격광전렬선완제술(HoLEP)화경뇨도등리자전렬선완제전절술(PKEP)치료량성전렬선증생(BPH)적림상효과.방법 선택아원2013년1월지2014년6월BPH환자공86례,분별접수HoLEP(HoLEP조,40례)혹PKEP(PKEP조,46례)치료,평개량조환자수술전급술후3개월잔여뇨량(PVR)、국제전렬선증상평분(IPSS),생활질량(QOL)평분,최대뇨류솔(MFR)등지표,병기록술중출혈량、수술시간、절제전렬선질량、방광충세시간、류치도뇨시간、술후주원시간등위수술기상관지표.결과 술후3개월,량조PVR、IPSS、QOL、MFR등지표교술전균현저개선(P치균위0.000),단조간비교차이균무통계학의의(P균＞0.05);HoLEP조술중출혈량저우PKEP조[(69.5±23.6) ml여(87.5±38.0)ml,P=0.011],기여지표비교차이균무통계학의의(P균＞0.05).결론 HoLEP화PKEP치료전렬선량성증생적림상효과상당,단HoLEP출혈량경소.
Objective To evaluate and compare the efficacy of holmium laser enucleation of the prostate(HoLEP) and plasmakineticenucleation of the prostate(PKEP) for treating benign prostatic hyperplasia (BPH).Methods A total of 86 cases of BPH were selected from the Shandong Energy Zibo Mining Group Co.Ltd Central Hospital from January 2013 to June 2014.The patients received either HoLEP (40 cases) or PKEP(46 cases) treatment.Clinical data including postvoid residual volume (PVR),international prostate symptom score(IPSS),quality-of-life score(QOL score),maximum urinary flow rate (MFR) were evaluated before and 3 months after operation.Blood loss in operation,operation time,weight of resected prostate tissue,bladder irrigation time,catheterization time and length of hospital stay were also collected from the perioperative period.Results Three months after surgery,PVR,IPSS,QOL and MFR were all significantly improved in both HoLEP and PKEP groups compared with the data before operation (P =0.000),while there was no significant difference between the two groups(P＞0.05).Patients from the HoLEP group showed markedly lower values of bone loss in operation than that of PKEP group((69.5±23.6) ml vs.(87.5±38.0) ml,P=0.011).There were no significant differences in terms of other indexes (P＞ 0.05).Conclusion HoLEP and PKEP have similar efficiency in treating BPH,while HoLEP is suggested superior in regard of bone loss.
